Cibus, Inc. (CBUS)
| Market Cap | 70.08M |
| Revenue (ttm) | 4.26M |
| Net Income (ttm) | -251.39M |
| Shares Out | 34.35M |
| EPS (ttm) | -10.83 |
| PE Ratio | n/a |
| Forward PE | n/a |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 86,939 |
| Open | 2.000 |
| Previous Close | 1.980 |
| Day's Range | 1.980 - 2.120 |
| 52-Week Range | 1.804 - 22.990 |
| Beta | 2.05 |
| Analysts | Strong Buy |
| Price Target | 22.17 (+986.77%) |
| Earnings Date | Mar 20, 2025 |
About CBUS
Cibus, Inc., an agricultural biotechnology company, develops and licenses plant traits to seed companies for royalties. It focuses on trait productivity in two areas, including productivity traits that enable farmers to have higher yields and reduce the use of the crop protection chemicals and fertilizers; and sustainable ingredients that enable corporations to replace ingredients that are fossil fuel based or linked to environmental challenges. Cibus, Inc. is headquartered in San Diego, California. [Read more]
Financial Performance
In 2024, Cibus's revenue was $4.26 million, an increase of 134.56% compared to the previous year's $1.82 million. Losses were -$251.39 million, -6.07% less than in 2023.
Financial StatementsAnalyst Forecast
According to 3 analysts, the average rating for CBUS stock is "Strong Buy." The 12-month stock price forecast is $22.17, which is an increase of 986.77% from the latest price.
News
Cibus, Inc. (CBUS) Q4 2024 Earnings Call Transcript
Cibus, Inc. (NASDAQ:CBUS) Q4 2024 Earnings Conference Call March 20, 2025 4:30 PM ET Company Participants Carlo Broos - Interim Chief Financial Officer Peter Beetham - Co-Founder, President and COO, ...
Cibus Reports Fourth Quarter Financial Results and Provides Business Update
A major milestone on March 14th 2025 advanced the EU Trilogue discussions aimed to complete the final text of the New Genomic Techniques (NGTs) or gene editing legislation for the EU; California Rice ...
Cibus Welcomes the European Union's Progress as Legislation for New Genomic Techniques to Boost Innovation and Sustainability Moves Forward
Legislation aims to adapt EU law to reflect scientific and technological progress, enabling the products of New Genomic Techniques (NGTs), such as gene editing, to contribute to more sustainable agric...
Cibus to Report Fourth Quarter 2024 Financial Results on March 20, 2025 After the Market Close and Host Conference Call
SAN DIEGO, March 11, 2025 (GLOBE NEWSWIRE) -- Cibus, Inc. (Nasdaq: CBUS), a leading agricultural biotechnology company that uses proprietary gene editing technologies to develop plant traits (or speci...
Cibus' Achieves Another Milestone for a Durable White Mold (Sclerotinia) Resistance Trait in Canola
Initial bioassay data for Cibus' third mode of action for white mold (Sclerotinia) resistance trait in canola shows promising results in controlled environment assessment
Cibus Announces Leadership Change and CEO Succession Plan
SAN DIEGO, Feb. 28, 2025 (GLOBE NEWSWIRE) -- Cibus, Inc. (Nasdaq: CBUS) (the “Company” or “Cibus”), a leading agricultural technology company that develops and licenses plant traits to seed companies ...
Cibus Announces Important Update to Rice Gene Editing Conversion Rates
SAN DIEGO, Feb. 14, 2025 (GLOBE NEWSWIRE) -- Cibus, Inc. (Nasdaq: CBUS) (the “Company” or “Cibus”), a leading agricultural technology company that develops and licenses plant traits to seed companies ...
Cibus to Participate in the Sidoti Micro Cap Conference
SAN DIEGO, Jan. 22, 2025 (GLOBE NEWSWIRE) -- Cibus, Inc. (Nasdaq: CBUS) (the “Company”), a leading agricultural biotechnology company that uses proprietary gene editing technologies to develop plant t...
Cibus, Inc. Announces $22.6 Million Registered Direct Offering Priced Above Nasdaq's Minimum Price in Accordance with Nasdaq Rules
SAN DIEGO, Jan. 21, 2025 (GLOBE NEWSWIRE) -- Cibus, Inc. (Nasdaq: CBUS) (the “Company” or “Cibus”), a leading agricultural biotechnology company that uses proprietary gene editing technologies to deve...
Cibus, Albaugh LLC and RTDC Company Limited Affirm Collaboration to Enable Commercialization of Cibus' First Gene Edited Weed Management Solution for U.S. Rice Growers
Cibus' Rice Herbicide Tolerance (HT-3) Commercialization Efforts Continue Promising Progress to deliver a new Weed Management Solution for Farmers in the U.S.
Cibus and Biographica Announce Collaboration Using Artificial Intelligence (AI) to Advance Disease Resistance in Canola and Oilseed Rape
Cibus and Biographica to collaborate on identifying gene editing targets for Cibus' disease resistance trait development
Cibus to Participate in the 13th Annual Roth Technology Conference
SAN DIEGO, Nov. 18, 2024 (GLOBE NEWSWIRE) -- Cibus, Inc. (Nasdaq: CBUS) (the “Company”), a leading agricultural technology company that develops and licenses plant traits to seed companies for royalti...
Cibus, Inc. (CBUS) Q3 2024 Earnings Call Transcript
Cibus, Inc. (NASDAQ:CBUS) Q3 2024 Results Conference Call November 7, 2024 4:30 PM ET Company Participants Carlo Broos - Chief Financial Officer Rory Riggs - Co-Founder, Chairman and CEO Peter Beetha...
Cibus Reports Third Quarter Financial Results and Provides Year-to-Date Business Update for 2024
Announced a strategic realignment to advance commercial opportunities, focusing resources on advancement of weed management platform (HT1 and HT3) for Rice, Pod Shatter Reduction in Canola, Sclerotini...
Cibus Confirms its Herbicide Tolerance (HT2) Trait Shows Increased Tolerance to a Novel Herbicide for Weed Control in Canola
The greenhouse results represent an important success milestone in the development of its second-generation of HT2 edited Canola
Cibus to Report Third Quarter 2024 Financial Results on November 7, 2024 After the Market Close and Host Conference Call
SAN DIEGO, Oct. 24, 2024 (GLOBE NEWSWIRE) -- Cibus, Inc. (Nasdaq: CBUS), a leading agricultural technology company that develops and licenses plant traits to seed companies for royalties, today announ...
Cibus Inc. Announces Realigned Organization to Advance its Commercial Opportunities
Projected Cost Savings of Approximately $10 Million on Annualized Run-Rate Basis and Expected to Reduce Cash Use by Approximately 20% Projected Cost Savings of Approximately $10 Million on Annualized ...
Cibus Technology to be Featured on InnovAction Stage at the Euroseeds2024 Congress
SAN DIEGO, Oct. 11, 2024 (GLOBE NEWSWIRE) -- Cibus, Inc. (Nasdaq: CBUS), a leading agricultural technology company that develops plant traits to license to seed companies for royalties, has been named...
Cibus to Participate in the Food+ Forum during the 79th Session of the United Nations General Assembly
SAN DIEGO, Sept. 23, 2024 (GLOBE NEWSWIRE) -- Cibus, Inc. (Nasdaq: CBUS), a leading agricultural technology company that develops plant traits to license to seed companies for royalties, today announc...
Cibus Announces Pricing of Public Offering of Class A Common Stock
SAN DIEGO, Sept. 18, 2024 (GLOBE NEWSWIRE) -- Cibus, Inc. (Nasdaq: CBUS) (the “Company” or “Cibus”), a leading agricultural biotechnology company that uses proprietary gene editing technologies to dev...
Cibus, Inc. Announces Proposed Public Offering of Class A Common Stock
SAN DIEGO, Sept. 17, 2024 (GLOBE NEWSWIRE) -- Cibus, Inc. (Nasdaq: CBUS), a leading agricultural biotechnology company that uses proprietary gene editing technologies to develop plant traits (or speci...
Cibus Completes First Field Trials in UK for Pod Shatter Reduction in Winter Oilseed Rape
Initial data from Pod Shatter Reduction field trials show promising results The first gene edited trait to complete field trials in oilseed rape in the UK SAN DIEGO, Sept. 10, 2024 (GLOBE NEWSWIRE) --...
Cibus to Participate in Upcoming August Investor Events
SAN DIEGO, Aug. 12, 2024 (GLOBE NEWSWIRE) -- Cibus, Inc. (Nasdaq: CBUS), a leading agricultural technology company that develops plant traits to license to seed companies for royalties, today announce...
Cibus, Inc. (CBUS) Q2 2024 Earnings Call Transcript
Cibus, Inc. (NASDAQ:CBUS) Q2 2024 Earnings Conference Call August 8, 2024 4:30 PM ET Company Participants Wade King - Chief Financial Officer Rory Riggs - Co-Founder, Chairman and CEO Peter Beetham -...
Cibus Achieves Positive Initial Field Trial Results for Stacked Gene Edited Herbicide Tolerant Traits in Rice
Early results of a novel weed management solution using two herbicides show promise. The first known use of stacked gene edited herbicide tolerant traits in an elite variety of rice to improve weed m...